The Vitamin D/CYP24A1 Story in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|10|3|213-224

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.3, 2010-03, pp. : 213-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implication of CYP24A1 Splicing in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 109-114

Bentham Science Publishers

Access to resources Recommend Favorite

CYP24A1 as a Potential Target for Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 97-108

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoprevention of Prostate Cancer by Cholecalciferol (Vitamin D3): 25-hydroxylase (CYP27A1) in Human Prostate Epithelial Cells

By Tokar Erik   Webber Mukta  

Clinical and Experimental Metastasis, Vol. 22, Iss. 3, 2005-05 ,pp. : 265-273

Springer Publishing Company

Access to resources Recommend Favorite

Cholecalciferol (Vitamin D3) Inhibits Growth and Invasion by Up-regulating Nuclear Receptors and 25-Hydroxylase (CYP27A1) in Human Prostate Cancer Cells

By Tokar Erik   Webber Mukta  

Clinical and Experimental Metastasis, Vol. 22, Iss. 3, 2005-05 ,pp. : 275-284

Springer Publishing Company

Access to resources Recommend Favorite

Sunlight Vitamin D and Skin Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 1, 2013-01 ,pp. : 83-97

Bentham Science Publishers

Access to resources Recommend Favorite